6th Annual Wellness Symposium: Mind and Body Therapies in MS
October 23, 2020
Join us virtually for this accredited, half-day symposium presented by the OHSU MS Wellness Research Group! We will explore the role of mind and body therapies in MS and generate research questions for future cross-disciplinary studies. This symposium brings together experts from OHSU, University of Toronto, and RAND Corporation.
Speakers will explore the neurobiological mechanisms of mind and body therapies in health and disease, the use of mind and body therapies in MS, evidence-based effectiveness of mind and body therapies in MS, and the economic impact of these therapies.
Who should attend
Basic scientists and clinicians with an interest in mind and body research. The symposium welcomes participants at all stages of expertise.
- Review the role of mind and body therapies in health and disease states
- Understand the neurological mechanisms by which mind and body therapies can influence health
- Describe prevalence and patterns of use of mind and body therapies in MS
- Discuss the evidence based effects of mind and body therapies in people with MS, including mindfulness-based interventions and stress reduction techniques on symptom management and quality of life
- Understand the economic impact of mind and body therapies, including the cost-effectiveness of mind and body therapies and the consequences of barriers to access of these therapies
Accreditation: The School of Medicine, Oregon Health & Science University (OHSU), is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit: Oregon Health & Science University School of Medicine designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
12:30 – 1 p.m.: Registration
1 – 1:15 p.m.: Introduction and welcome
Rebecca Spain, M.D., M.S.P.H.
1:15 – 2 p.m.: An overview of mind and body therapies in MS
Elizabeth Silbermann, M.D.
2:05 – 2:50 p.m.: Neurobiological mechanisms of mind and body therapies
Barry Oken, M.D., Ph.D.
2:55 – 3:10 p.m.: Break
3:10 – 3:55 p.m.: Evidence-based effects of mind and body therapies in MS
Robert Simpson, MBChB, Ph.D.
University of Toronto
4 – 4:45 p.m.: Economic impact of mind and body therapies
Patricia Herman, N.D., Ph.D.
4:45 – 5:15 p.m.: Panel discussion
5:15 – 7 p.m.: Reception
1–1:15 p.m.: Introduction and Welcome
Rebecca Spain, M.D., M.S.P.H.
1:15–2 p.m.: An overview of the microbiome in health and disease
Thomas Sharpton, Ph.D.
Oregon State University
2:05–2:50 p.m.: The role of the microbiome and the gut–brain axis
Michael Lane, M.D.
3:10–3:55 p.m.: Evidence for the influence of the microbiome in EAE
Laura Piccio, M.D., Ph.D.
Washington University in St. Louis
4:00–4:45 p.m.: Evidence for the influence of the microbiome in MS
Ilana Katz Sand, M.D.
Icahn School of Medicine, Mount Sinai Hospital
4:45–5:15 p.m.: Panel discussion